J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 392.8
1 976
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one JBCHEPHARM stock under the Base Case scenario is 1 190.38 INR. Compared to the current market price of 1 743.4 INR, J B Chemicals and Pharmaceuticals Ltd is Overvalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
J B Chemicals and Pharmaceuticals Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for JBCHEPHARM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
J B Chemicals and Pharmaceuticals Ltd
Balance Sheet Decomposition
J B Chemicals and Pharmaceuticals Ltd
Current Assets | 18.5B |
Cash & Short-Term Investments | 3.9B |
Receivables | 8.6B |
Other Current Assets | 6B |
Non-Current Assets | 21.4B |
Long-Term Investments | 285.1m |
PP&E | 6.3B |
Intangibles | 14.5B |
Other Non-Current Assets | 314.7m |
Current Liabilities | 8.7B |
Accounts Payable | 3.6B |
Short-Term Debt | 153.4m |
Other Current Liabilities | 5B |
Non-Current Liabilities | 2B |
Long-Term Debt | 332.8m |
Other Non-Current Liabilities | 1.7B |
Earnings Waterfall
J B Chemicals and Pharmaceuticals Ltd
Revenue
|
35.9B
INR
|
Cost of Revenue
|
-12.1B
INR
|
Gross Profit
|
23.8B
INR
|
Operating Expenses
|
-15.8B
INR
|
Operating Income
|
8B
INR
|
Other Expenses
|
-2.1B
INR
|
Net Income
|
5.9B
INR
|
Free Cash Flow Analysis
J B Chemicals and Pharmaceuticals Ltd
INR | |
Free Cash Flow | INR |
JBCHEPHARM Profitability Score
Profitability Due Diligence
J B Chemicals and Pharmaceuticals Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
J B Chemicals and Pharmaceuticals Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
JBCHEPHARM Solvency Score
Solvency Due Diligence
J B Chemicals and Pharmaceuticals Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Score
J B Chemicals and Pharmaceuticals Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JBCHEPHARM Price Targets Summary
J B Chemicals and Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for JBCHEPHARM is 2 130.78 INR with a low forecast of 1 702.86 INR and a high forecast of 2 446.5 INR.
Dividends
Current shareholder yield for JBCHEPHARM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
JBCHEPHARM Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 4,340 full-time employees. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The firm is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). The company is involved in the provision of product development services. The firm offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The firm exports its products to over 40 countries across the world.
Contact
IPO
Employees
Officers
The intrinsic value of one JBCHEPHARM stock under the Base Case scenario is 1 190.38 INR.
Compared to the current market price of 1 743.4 INR, J B Chemicals and Pharmaceuticals Ltd is Overvalued by 32%.